ArticleMultidisciplinary respiratory medicine2016

Efficacy of recombinant human soluble thrombomodulin for the treatment of acute exacerbation of idiopathic pulmonary fibrosis: a single arm, non-randomized prospective clinical trial.

Sho Hayakawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.